516 related articles for article (PubMed ID: 27912784)
1. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.
Rizvi AA; Patti AM; Giglio RV; Nikolic D; Amato A; Al-Busaidi N; Al-Rasadi K; Soresi M; Banach M; Montalto G; Rizzo M
Expert Opin Biol Ther; 2015; 15(10):1391-7. PubMed ID: 26195184
[TBL] [Abstract][Full Text] [Related]
3. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.
Lambadiari V; Pavlidis G; Kousathana F; Varoudi M; Vlastos D; Maratou E; Georgiou D; Andreadou I; Parissis J; Triantafyllidi H; Lekakis J; Iliodromitis E; Dimitriadis G; Ikonomidis I
Cardiovasc Diabetol; 2018 Jan; 17(1):8. PubMed ID: 29310645
[TBL] [Abstract][Full Text] [Related]
4. Effect of Liraglutide on Arterial Inflammation Assessed as [
Ripa RS; Zobel EH; von Scholten BJ; Jensen JK; Binderup T; Diaz LJ; Curovic VR; Hansen TW; Rossing P; Kjaer A
Circ Cardiovasc Imaging; 2021 Jul; 14(7):e012174. PubMed ID: 34187185
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.
Nikolic D; Giglio RV; Rizvi AA; Patti AM; Montalto G; Maranta F; Cianflone D; Stoian AP; Rizzo M
Diabetes Ther; 2021 Jan; 12(1):261-274. PubMed ID: 33210276
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.
Rizzo M; Chandalia M; Patti AM; Di Bartolo V; Rizvi AA; Montalto G; Abate N
Cardiovasc Diabetol; 2014 Feb; 13():49. PubMed ID: 24559258
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study.
Nikolic D; Patti AM; Giglio RV; Chianetta R; Castellino G; Magán-Fernández A; Citarrella R; Papanas N; Janez A; Stoian AP; Rizvi AA; Rizzo M
Diabetes Ther; 2022 Mar; 13(3):453-464. PubMed ID: 35167051
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial.
Zhang J; Xian TZ; Wu MX; Li C; Pan Q; Guo LX
Cardiovasc Diabetol; 2020 Apr; 19(1):48. PubMed ID: 32334592
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy.
Irace C; Casciaro F; Scavelli FB; Oliverio R; Cutruzzolà A; Cortese C; Gnasso A
Cardiovasc Diabetol; 2018 Apr; 17(1):52. PubMed ID: 29631585
[TBL] [Abstract][Full Text] [Related]
10. Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium.
Koskinen J; Magnussen CG; Sinaiko A; Woo J; Urbina E; Jacobs DR; Steinberger J; Prineas R; Sabin MA; Burns T; Berenson G; Bazzano L; Venn A; Viikari JSA; Hutri-Kähönen N; Raitakari O; Dwyer T; Juonala M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862940
[TBL] [Abstract][Full Text] [Related]
11. Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.
Jendle J; Hyötyläinen T; Orešič M; Nyström T
Cardiovasc Diabetol; 2021 Dec; 20(1):237. PubMed ID: 34920733
[TBL] [Abstract][Full Text] [Related]
12. The echogenicity of the intima-media complex in the common carotid artery is related to insulin resistance measured by the hyperinsulinemic clamp in elderly men.
Lind L; Wohlin M; Andren B; Sundström J
Clin Physiol Funct Imaging; 2013 Mar; 33(2):137-42. PubMed ID: 23383692
[TBL] [Abstract][Full Text] [Related]
13. Impact of cardiovascular risk factors on carotid intima-media thickness: sex differences.
Łoboz-Rudnicka M; Jaroch J; Bociąga Z; Rzyczkowska B; Uchmanowicz I; Polański J; Dudek K; Szuba A; Łoboz-Grudzień K
Clin Interv Aging; 2016; 11():721-31. PubMed ID: 27307718
[TBL] [Abstract][Full Text] [Related]
14. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study.
Novo S; Peritore A; Guarneri FP; Corrado E; Macaione F; Evola S; Novo G
Atherosclerosis; 2012 Aug; 223(2):468-72. PubMed ID: 22704563
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome showed significant relationship with carotid atherosclerosis.
Kawada T; Andou T; Fukumitsu M
Heart Vessels; 2016 May; 31(5):664-70. PubMed ID: 25810113
[TBL] [Abstract][Full Text] [Related]
18. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
19. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
[TBL] [Abstract][Full Text] [Related]
20. Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients.
Mombelli G; Pavanello C; Castelnuovo S; Bosisio R; Simonelli S; Pazzucconi F; Sirtori CR
Curr Vasc Pharmacol; 2017; 15(3):248-256. PubMed ID: 28128067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
